These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 9174612
1. Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death-inducing signaling complex. Peter ME, Kischkel FC, Scheuerpflug CG, Medema JP, Debatin KM, Krammer PH. Eur J Immunol; 1997 May; 27(5):1207-12. PubMed ID: 9174612 [Abstract] [Full Text] [Related]
2. Apoptosis induced by a chimeric Fas/FLICE receptor: lack of requirement for Fas- or FADD-binding proteins. Memon SA, Hou J, Moreno MB, Zacharchuk CM. J Immunol; 1998 Mar 01; 160(5):2046-9. PubMed ID: 9498739 [Abstract] [Full Text] [Related]
3. Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas- and Bax-mediated programmed cell death. Boussiotis VA, Lee BJ, Freeman GJ, Gribben JG, Nadler LM. J Immunol; 1997 Oct 01; 159(7):3156-67. PubMed ID: 9317113 [Abstract] [Full Text] [Related]
4. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression. Fulda S, Meyer E, Debatin KM. Cancer Res; 2000 Jul 15; 60(14):3947-56. PubMed ID: 10919673 [Abstract] [Full Text] [Related]
5. Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis. Algeciras-Schimnich A, Griffith TS, Lynch DH, Paya CV. J Immunol; 1999 May 01; 162(9):5205-11. PubMed ID: 10227994 [Abstract] [Full Text] [Related]
6. Inhibition of death receptor signals by cellular FLIP. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schröter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J. Nature; 1997 Jul 10; 388(6638):190-5. PubMed ID: 9217161 [Abstract] [Full Text] [Related]
7. Fas-mediated apoptosis in neuroblastoma requires mitochondrial activation and is inhibited by FLICE inhibitor protein and Bcl-2. Poulaki V, Mitsiades N, Romero ME, Tsokos M. Cancer Res; 2001 Jun 15; 61(12):4864-72. PubMed ID: 11406564 [Abstract] [Full Text] [Related]
8. Apoptosis signaling pathways in normal T cells: differential activity of Bcl-2 and IL-1beta-converting enzyme family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity. Moreno MB, Memon SA, Zacharchuk CM. J Immunol; 1996 Nov 01; 157(9):3845-9. PubMed ID: 8892614 [Abstract] [Full Text] [Related]
9. CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma. Mezzanzanica D, Balladore E, Turatti F, Luison E, Alberti P, Bagnoli M, Figini M, Mazzoni A, Raspagliesi F, Oggionni M, Pilotti S, Canevari S. Clin Cancer Res; 2004 Aug 01; 10(15):5202-14. PubMed ID: 15297424 [Abstract] [Full Text] [Related]
10. Selective up-regulation of phosphatidylinositol 3'-kinase activity in Th2 cells inhibits caspase-8 cleavage at the death-inducing complex: a mechanism for Th2 resistance from Fas-mediated apoptosis. Varadhachary AS, Peter ME, Perdow SN, Krammer PH, Salgame P. J Immunol; 1999 Nov 01; 163(9):4772-9. PubMed ID: 10528176 [Abstract] [Full Text] [Related]
11. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis. Fulda S, Meyer E, Friesen C, Susin SA, Kroemer G, Debatin KM. Oncogene; 2001 Mar 01; 20(9):1063-75. PubMed ID: 11314043 [Abstract] [Full Text] [Related]
12. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells. An S, Yap D, Knox KA. Cell Immunol; 1997 Nov 01; 181(2):139-52. PubMed ID: 9398401 [Abstract] [Full Text] [Related]
13. Cholangiocarcinomas express Fas ligand and disable the Fas receptor. Que FG, Phan VA, Phan VH, Celli A, Batts K, LaRusso NF, Gores GJ. Hepatology; 1999 Dec 01; 30(6):1398-404. PubMed ID: 10573518 [Abstract] [Full Text] [Related]
14. TCR engagement regulates differential responsiveness of human memory T cells to Fas (CD95)-mediated apoptosis. Di Somma MM, Somma F, Gilardini Montani MS, Mangiacasale R, Cundari E, Piccolella E. J Immunol; 1999 Apr 01; 162(7):3851-8. PubMed ID: 10201902 [Abstract] [Full Text] [Related]
15. Cell death attenuation by 'Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex. Rasper DM, Vaillancourt JP, Hadano S, Houtzager VM, Seiden I, Keen SL, Tawa P, Xanthoudakis S, Nasir J, Martindale D, Koop BF, Peterson EP, Thornberry NA, Huang J, MacPherson DP, Black SC, Hornung F, Lenardo MJ, Hayden MR, Roy S, Nicholson DW. Cell Death Differ; 1998 Apr 01; 5(4):271-88. PubMed ID: 10200473 [Abstract] [Full Text] [Related]
16. Inhibition of CD95 apoptotic signaling by interferon-gamma in human osteoarthritic chondrocytes is associated with increased expression of FLICE inhibitory protein. Grassi F, Piacentini A, Cristino S, Toneguzzi S, Facchini A, Lisignoli G. Arthritis Rheum; 2004 Feb 01; 50(2):498-506. PubMed ID: 14872492 [Abstract] [Full Text] [Related]
17. MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly. Holmström TH, Schmitz I, Söderström TS, Poukkula M, Johnson VL, Chow SC, Krammer PH, Eriksson JE. EMBO J; 2000 Oct 16; 19(20):5418-28. PubMed ID: 11032809 [Abstract] [Full Text] [Related]
18. Differential regulation of Fas-mediated apoptosis of rheumatoid synoviocytes by tumor necrosis factor alpha and basic fibroblast growth factor is associated with the expression of apoptosis-related molecules. Kobayashi T, Okamoto K, Kobata T, Hasunuma T, Kato T, Hamada H, Nishioka K. Arthritis Rheum; 2000 May 16; 43(5):1106-14. PubMed ID: 10817565 [Abstract] [Full Text] [Related]
19. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation. Hamaï A, Richon C, Meslin F, Faure F, Kauffmann A, Lecluse Y, Jalil A, Larue L, Avril MF, Chouaib S, Mehrpour M. Oncogene; 2006 Dec 07; 25(58):7618-34. PubMed ID: 16983347 [Abstract] [Full Text] [Related]
20. Isolation and analysis of components of CD95 (APO-1/Fas) death-inducing signaling complex. Scaffidi C, Krammer PH, Peter ME. Methods; 1999 Apr 07; 17(4):287-91. PubMed ID: 10196099 [Abstract] [Full Text] [Related] Page: [Next] [New Search]